TITLE

Increased mortality among HIV-positive men on antiretroviral therapy: survival differences between sexes explained by late initiation in Uganda

AUTHOR(S)
Kanters, Steve; Nansubuga, Margaret; Mwehire, Daniel; Odiit, Mary; Kasirye, Margaret; Musoke, William; Druyts, Eric; Yaya, Sanni; Funk, Anna; Ford, Nathan; Mills, Edward J
PUB. DATE
May 2013
SOURCE
HIV/AIDS - Research & Palliative Care;May2013, Vol. 5, p111
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: We aimed to assess the relationship between gender and survival among adult patients newly enrolled on antiretroviral therapy (ART) in Uganda. We also specifically examined the role of antenatal services in favoring women's access to HIV care. Methods: From an observational cohort study, we assessed survival and used logistic regression and differences in means to compare men and women who did not access care through antenatal services. Differences were assessed on measures of disease progression (WHO stage and CD4 count) and demographic (age, marital status, and education), behavioral (sexual activity, disclosure to partner, and testing), and clinical variables (hepatitis B and C, syphilis, malaria, and anemia). A mediational analysis that considered gender as the initial variable, time to death as the outcome, initial CD4 count as the mediator, and age as a covariate was performed using an accelerated failure time model with a Weibull distribution. Results: Between 2004 and 2011, a total of 4775 patients initiated ART, and after exclusions 4537 (93.2%) were included in analysis. Men initiating ART were more likely to have a WHO disease stage III or IV (odds ratio: 1.46, 95% confidence interval [CI]: 1.29-1.66), and lower CD4 cell counts compared to women (median baseline CD4 124 cells/mm3, interquartile range [IQR]: 43-205 versus 147 cells/mm3, IQR: 68-212, P-value , 0.0001). Men were at an increased risk of death compared to women (hazard ratio: 1.38, 95% CI: 1.03-1.83). Baseline CD4 cell counts accounted for 43% of the increased risk of death in men (95% CI: 22%-113%). Access to care via antenatal services did not explain differences in outcomes. Conclusion: In this cohort there is a marked increase in risk of mortality for men and approximatly half of it can be attributed to their later engagement in care. More effort is required to engage men in care in a timely manner
ACCESSION #
88016184

 

Related Articles

  • The contribution of antenatal care to the coverage and correlates of HIV testing among adults in Zimbabwe 2005-06. Saito, S.; Wu, Y.; Nankabirwa, V.; Nash, D. // International Journal of STD & AIDS;May2012, Vol. 23 Issue 5, p308 

    Expanding the availability, utilization and coverage of HIV testing services is a critical step towards primary prevention and successful delivery of antiretroviral therapy (ART) in Zimbabwe. We used data from the Zimbabwe Demographic and Health Survey (2005-2006) to examine the coverage and...

  • Incidence of Cytomegalovirus IgG Among HIV Positive Patients Attending Aminu Kano Teaching Hospital Kano-Nigeria. Hamid, K. M.; Takalmawa, H. U.; Onoja, B. A. // E-International Scientific Research Journal;Apr-Jun2012, Vol. 4 Issue 2, p98 

    A detection of cytomegalovirus IgG antibodies was carried out among HIV infected subject attending Aminu Kano Teaching Hospital Kano. A total of 90 subjects were enrolled for the study. The studied populations were divided into two groups, Pre-HAART and HAART groups. The serum samples were...

  • Factors Influencing Adherence to Antiretroviral Treatment in Nepal: A Mixed-Methods Study. Wasti, Sharada P.; Simkhada, Padam; Randall, Julian; Freeman, Jennifer V.; Teijlingen, Edwin van // PLoS ONE;May2012, Vol. 7 Issue 5, p1 

    Background: Antiretroviral therapy (ART) is a lifesaver for individual patients treated for Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS). Maintaining optimal adherence to antiretroviral drugs is essential for HIV infection management. This study aimed to...

  • Use of HIV and Psychotropic Medications among Persons with Serious Mental Illness and HIV/AIDS. Lee, Sungeun; Rothbard, Aileen; Noll, Elizabeth; Blank, Michael // Administration & Policy in Mental Health & Mental Health Service;Sep2011, Vol. 38 Issue 5, p335 

    Persons with serious mental illness (SMI) have higher rates of co-morbid HIV disorders compared to the general population. There are concerns that the SMI/HIV population may be receiving fewer HIV and psychotropic medications due to problems of access and concerns by providers associated with...

  • HAART and Progression to High-Grade Anal Intraepithelial Neoplasia in Men Who Have Sex with Men and Are Infected with HIV. de Pokomandy, Alexandra; Rouleau, Danielle; Ghattas, George; Trottier, Helen; Vézina, Sylvie; Coté, Pierre; Macleod, John; Allaire, Guy; Hadjeres, Rachid; Franco, Eduardo L.; Coutlée, François // Clinical Infectious Diseases;May2011, Vol. 52 Issue 9, p1174 

    Anal infection with HPV16 and/or HPV18 and a low nadir CD4 count increased the risk of high-grade AIN in HIV-seropositive men having sex with men. Being on the same HAART for over 4 years may contribute some benefit against high-grade AIN.(See the editorial commentary by Severini, on pages...

  • Systemic Immune Activation and Microbial Translocation in Dual HIV/Tuberculosis-Infected Subjects. Toossi, Zahra; Funderburg, Nicholas T.; Sirdeshmuk, Sohani; Whalen, Christopher C.; Nanteza, Maria W.; Johnson, Denise F.; Mayanja-Kizza, Harriet; Hirsch, Christina S. // Journal of Infectious Diseases;Jun2013, Vol. 207 Issue 12, p1841 

    Background. Systemic immune activation is a strong predictor of progression of human immunodeficiency virus type 1 (HIV-1) disease and a prominent feature of infection with Mycobacterium tuberculosis.Objective. To understand the role of systemic immune activation and microbial translocation in...

  • Current understanding in HIV immunopathology and treatment. Williams, J. P.; Frater, J. // QJM: An International Journal of Medicine;Aug2012, Vol. 105 Issue 8, p725 

    No abstract available.

  • Long-term Mortality in HIV-Positive Individuals Virally Suppressed for >3 Years With Incomplete CD4 Recovery. Engsig, Frederik N.; Zangerle, Robert; Katsarou, Olga; Dabis, Francois; Reiss, Peter; Gill, John; Porter, Kholoud; Sabin, Caroline; Riordan, Andrew; Fätkenheuer, Gerd; Gutiérrez, Félix; Raffi, Francois; Kirk, Ole; Mary-Krause, Murielle; Stephan, Christoph; de Olalla, Patricia Garcia; Guest, Jodie; Samji, Hasina; Castagna, Antonella; d'Arminio Monforte, Antonella // Clinical Infectious Diseases;May2014, Vol. 58 Issue 9, p1312 

    Virally suppressed HIV-positive individuals on combination antiretroviral therapy who do not achieve a CD4 count >200 cells/µL have substantially increased long-term mortality. The increased mortality was seen across different patient groups and for all causes of death.Background. Some human...

  • Comparison of HIV-1 Genotypic Resistance Test Interpretation Systems in Predicting Virological Outcomes Over Time. Frentz, Dineke; Boucher, Charles A. B.; Assel, Matthias; Luca, Andrea De; Fabbiani, Massimiliano; Incardona, Francesca; Libin, Pieter; Manca, Nino; Müller, Viktor; Breanndán Ó Nualláin; Paredes, Roger; Prosperi, Mattia; Quiros-Roldan, Eugenia; Ruiz, Lidia; Sloot, Peter M. A.; Torti, Carlo; Vandamme, Anne-Mieke; Laethem, Kristel Van; Zazzi, Maurizio; Vijver, David A. M. C. van de // PLoS ONE;2010, Vol. 5 Issue 7, p1 

    Background: Several decision support systems have been developed to interpret HIV-1 drug resistance genotyping results. This study compares the ability of the most commonly used systems (ANRS, Rega, and Stanford's HIVdb) to predict virological outcome at 12, 24, and 48 weeks....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics